BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
199 hedge funds and large institutions have $2.88B invested in bluebird bio in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
3% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 30
1% less funds holding
Funds holding: 200 → 199 (-1)
4% less capital invested
Capital invested by funds: $3.01B → $2.88B (-$134M)
Holders
199
Holding in Top 10
3
Calls
$50.2M
Puts
$44M
Top Buyers
| 1 | +$67M | |
| 2 | +$44.4M | |
| 3 | +$31.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.9M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$20.8M |
Top Sellers
| 1 | -$55.7M | |
| 2 | -$44.3M | |
| 3 | -$19.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$14.6M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$12.9M |